A

Addus HomeCare Corp

ADUS Nasdaq Healthcare · Services-Home Health Care Services Frisco, TX addus.com
$121.54
Mkt Cap 2.27B
Addus has been providing home care services since 1979. We operate three segments: personal care, hospice, and home health. Our services are principally provided in-home under agreements with federal,…

Addus has been providing home care services since 1979. We operate three segments: personal care, hospice, and home health. Our services are principally provided in-home under agreements with federal, state and local government agencies, managed care organizations, commercial insurers and private individuals. Our consumers are predominantly dual eligible, meaning they are eligible to receive both Medicare and Medicaid benefits. As of December 31, 2025, we provided services in 23 states through approximately 262 offices. For the year ended December 31, 2025, we served approximately 107,000 discrete consumers. We continue to drive organic growth while also growing through acquisitions, focusing on growth in the states in which we have a presence while adding clinical care services to our offerings. As of December 31, 2025, we provide all three levels of care, personal care, home health and hospice services, in Ohio, Tennessee, Illinois and New Mexico and strategically continue to pursue other markets. A summary of our financial results is provided in the table below. For the Years Ended December 31, 2025 2024 (Amounts in Thousands) Personal care $ 1,089,215 $ 856,581 Hospice 262,542 228,191 Home health 70,773 69,827 Total net service revenue by segment $ 1,422,530 $ 1,154,599 Net income $ 95,910 $ 73,598 Total assets $ 1,437,308 $ 1,412,634 Our services and operating model address a number of crucial needs across the healthcare continuum. Care provided in the home generally costs less than facility-based care and is typically preferred by consumers and their families.

/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$1.48B
FCF TTM
$123.1M
P/E RATIO
21.5x
P/FCF
18.4x
Running full 6-factor analysis…